Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shamsher Pasha"'
Autor:
Oliver Standring, Susana Benitez Sanchez, Shamsher Pasha, Lyudmyla Demyan, Neha Lad, Samantha M. Ruff, Sandeep Anantha, Martin Karpeh, Elliot Newman, William Nealon, Mark Talamini, Gene Coppa, Gary Deutsch, Matthew Weiss, Danielle K. DePeralta
Publikováno v:
Annals of Surgical Oncology.
Autor:
Oliver Standring, Susana Benitez Sanchez, Shamsher Pasha, Lyudmyla Demyan, Neha Lad, Samantha M. Ruff, Sandeep Anantha, Martin Karpeh, Elliot Newman, William Nealon, Mark Talamini, Gene Coppa, Gary Deutsch, Matthew Weiss, Danielle K. DePeralta
Publikováno v:
Annals of Surgical Oncology.
Autor:
Jun Yu, Joseph R. Habib, Elliot K. Fishman, Elizabeth D. Thompson, Sami Shoucair, Ammar A. Javed, William R. Burns, Shamsher Pasha, Subhan Khan, Jin He, Kelly J. Lafaro, Benedict Kinny-Köster, Brigitte M. Ronnett, Richard A. Burkhart, Ralph H. Hruban, Christopher L. Wolfgang
Publikováno v:
World Journal of Surgery. 45:3157-3164
Pancreatic ductal adenocarcinoma (PDAC) has a high propensity for systemic dissemination. Ovarian metastases are rare and poorly described. We identified PDAC cases with ovarian metastasis from a prospectively maintained registry. We reported on the
Autor:
Dylan Cooper, Baho Sidiqi, Ruwan Parakrama, Lyudmyla Demyan, Shamsher Pasha, Danielle Pinto, Tiffany Zavadsky, Xianghui Zou, Sunita Patruni, Adrianna Kapusta, Oliver Standring, Jason Nosrati, Leila T Tchelebi, Matthew John Weiss, Joseph M. Herman, Daniel King
Publikováno v:
Journal of Clinical Oncology. 41:695-695
695 Background: Significant variation exists in the management of potentially resectable pancreatic ductal adenocarcinoma (PDAC) across healthcare systems. We describe the results of a newly implemented neoadjuvant therapy pathway (NATP) in New York
Autor:
Ruwan Parakrama, Baho Sidiqi, Lyudmyla Demyan, Shamsher Pasha, Danielle Pinto, Tiffany Zavadsky, Xianghui Zhou, Sunita Patruni, Adrianna Kapusta, Oliver Standring, Matthew J. Weiss, Joseph M. Herman, Daniel A. King
Publikováno v:
Cancer Research. 82:A022-A022
Optimal management of patients with potentially resectable pancreatic ductal adenocarcinoma (PDAC) is controversial and variation exists within/across academic and healthcare systems. Herein we describe the initial results of a neoadjuvant therapy (N
Autor:
Joseph R, Habib, Shamsher, Pasha, Subhan, Khan, Benedict, Kinny-Köster, Sami, Shoucair, Elizabeth D, Thompson, Jun, Yu, Kelly, Lafaro, Richard A, Burkhart, William R, Burns, Brigitte M, Ronnett, Christopher L, Wolfgang, Ralph H, Hruban, Jin, He, Elliot K, Fishman, Ammar A, Javed
Publikováno v:
World journal of surgery. 45(10)
Pancreatic ductal adenocarcinoma (PDAC) has a high propensity for systemic dissemination. Ovarian metastases are rare and poorly described.We identified PDAC cases with ovarian metastasis from a prospectively maintained registry. We reported on the a